Lethal form of a late-onset aquaporin-4 antibody-positive NMOSD related to the immune checkpoint inhibitor nivolumab

J Neurol. 2022 May;269(5):2778-2780. doi: 10.1007/s00415-021-10913-y. Epub 2021 Nov 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aquaporin 4
  • Autoantibodies
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Neuromyelitis Optica* / diagnostic imaging
  • Neuromyelitis Optica* / drug therapy
  • Nivolumab* / adverse effects

Substances

  • Aquaporin 4
  • Autoantibodies
  • Immune Checkpoint Inhibitors
  • Nivolumab